Skip to content
Screener

Strata Critical Medical SRTA Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$70.8MMiss by $9.1M
EPS-$0.05Miss by $0.01
Revenue estimate$79.9M
EPS estimate-$0.04

Next report

Nov 9, 2026 (In 3 weeks)
Revenue estimate$72.7M
EPS estimate$0.01

Financials

Q2 2025

Income statement

See full
Revenue$70.8M+4.2%
Gross profit$17.7M+8.5%
Operating income-$5.0M+59.2%
Net income-$3.7M+67.0%
EPS (diluted)-$0.05+66.7%

Balance sheet

See full
Cash & equivalents$60.3M+113%
Total debt$8.8M-59.8%
Total equity$223.1M-2.7%
Total assets$257.9M-8.0%

Cash flow

See full
Operating cash flow-$3.1M—
CapEx$2.3M-85.7%
Free cash flow-$5.4M+30.6%

Valuation & ratios

Profitability

See full
Gross margin20.8%-0.6pp
Operating margin-13.2%-4.5pp
Net margin-10.6%-3.5pp
FCF margin-9.8%-2.3pp

Returns & leverage

See full
Return on equity-8.4%-3.1pp
Debt / equity0×-0.1×
Current ratio5.9×-0.1×

FAQ

When did Strata Critical Medical report Q2 2025 earnings?
Strata Critical Medical (SRTA) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Strata Critical Medical's Q2 2025 revenue and EPS?
Strata Critical Medical reported revenue of $70.8M and eps of $-0.05 for Q2 2025.
Did Strata Critical Medical beat estimates in Q2 2025?
Revenue missed the consensus estimate of $79.9M by $9.1M. EPS missed the consensus estimate of $-0.04 by $0.01.
How did Strata Critical Medical's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.2% from $67.9M a year earlier and eps grew 16.7% from $-0.06.
Where can I find Strata Critical Medical's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-073338) and the 10-Q periodic report (0001779128-25-000060) directly on SEC EDGAR. The filing index links above go to sec.gov.